BRO vs SOFI

The Advanced Deterministic Scorecard reveals a mixed health profile with a weak Piotroski F-Score of 4/9, indicating borderline financial stability, and no available Altman Z-Score to assess bankruptcy risk. Despite strong revenue growth of 34.20% and solid profitability metrics like a 27.36% operating margin, earnings have declined YoY by -16.10%, creating a divergence between top-line and bottom-line performance. The stock trades above its Graham Number of $52.48 at $79.18, reflecting a premium valuation supported by growth expectations and sector outperformance in revenue. Analysts concur with a 'hold' recommendation, while insider sentiment is neutral and technical indicators suggest bearish momentum.

SOFI exhibits a stark divergence between its growth trajectory and its deterministic financial health, highlighted by a weak Piotroski F-Score of 2/9. While the company demonstrates impressive revenue growth of 40.20% and a consistent track record of earnings beats, it trades at a significant premium to its Graham Number ($8.51) and Intrinsic Value ($2.73). The current price of $19.43 reflects high market expectations for future scaling rather than current fundamental value. Overall, the stock is a speculative growth play with deteriorating short-term financial health metrics and bearish insider sentiment.